New CDC Director Says Vaccines Are 'Safe and Effective'

Seeking Alpha4minutes ago

Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions

Benzinga11minutes ago

Pfizer Stock Rises Wednesday: What's Going On?

Benzinga46minutes ago

Moderna’s stock price doubled as Merck & Co announced the success of Phase III trials for its mRNA cancer vaccine, marking a historic breakthrough in melanoma treatment.

Moderna and Merck & Co announced on Wednesday that their jointly developed personalized mRNA cancer vaccine achieved positive results in a large-scale Phase III clinical trial. This marks the first successful Phase III trial for mRNA technology in the field of cancer treatment and represents a major breakthrough for personalized immunotherapy in the history of oncology.

wallstreetcnAug 19 21:33

U.S. HR stocks stage a strong rebound: As AI-generated resumes flood the market, recruitment firms gain greater value!

AI has not disrupted the U.S. recruitment industry; instead, the proliferation of AI-generated resumes has heightened the value of candidate screening, creating new demand for human resources firms. Recruitment stocks such as ManpowerGroup and Robert Half have reported earnings that exceeded expectations, with share prices rebounding strongly from their lows. While AI has become a tool for enhancing industry efficiency, valuations face pressure following the rebound. The long-term trajectory will depend on the recovery of the U.S. labor market and whether recruitment firms can truly capitalize on AI benefits.

wallstreetcnAug 18 23:53

Stock Index Futures Slide as Wall Street Looks at Another Red Day

Seeking AlphaAug 18 16:18